Subscribe

Chaoju Eye Care Holdings Limited (2219.HK)

HKD2.55 +0.00 (+0.00%)
CN HKSE Healthcare Medical - Care Facilities
Address Shouke Building
Beijing, CN
CEO Bo Zhou Zhang
Website chaojueye.com
IPO 2021-07-07
ISIN KYG2047K1094

Explore sections of this company profile

Description

Chaoju Eye Care Holdings Limited owns and operates a network of ophthalmic hospitals and optical centers in China. Its consumer ophthalmic services include treatments and prevention for various ophthalmic disorders, such as refractive and presbyopia correction, myopia prevention and control, dry eye syndrome, and oculoplastic, as well as optical products and services. The company also provides treatment for eye diseases, including cataract, glaucoma, squint, ocular fundus diseases, ocular surface diseases, orbital diseases, and pediatric eye diseases. In addition, it offers Amblyopia recovery services; and sells eyewear, equipment, and optical products. Chaoju Eye Care Holdings Limited was founded in 1988 and is headquartered in Beijing, China.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
HKD2.55 +0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
511.6K
Beta
0.55
Float Shares
301.53M
Free Float %
43.5%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+1.18% -1.53% -14.00% -5.49% -1.90% -6.18% -7.53% -41.63% -81.70% -81.70% -81.70%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
2.55
DCF (Unlevered) 11.87 +365.3%
DCF (Levered) 15.58 +511.1%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM)
Rating 2026-05 Change
Strong Buy 0 0
Buy 0 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
3.45
Safe zone
Piotroski F-Score
5 / 9
Average
MOAT Score
6 / 10
Developing
Composite Rating
A+
Overall Score
4 / 5
High
DCF Score
5 / 5
High
ROE Score
4 / 5
High
ROA Score
5 / 5
High
D/E Score
3 / 5
Medium
P/E Score
3 / 5
Medium
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
  • ✗
    Revenue growth Medical - Care Facilities: +10.2%
    -3.2% Q4'25: -2.2% (vs Q4'23)
  • ✗
    EPS growth Medical - Care Facilities: +19.2%
    -7.1% Q4'25: -11.5% (vs Q4'23)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +11.5% Q4'25: +6.5% (vs Q4'23)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +17.8% ★ Q4'25: +14.5% (vs Q4'23)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +14.5% ★ Q4'25: +21.4% (vs Q4'23)
  • ✗
    Share dilution Medical - Care Facilities: +0.0%
    +0.8% Q4'25: +1.3% (vs Q4'23)
  • ✓
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    0.72× ★ Q4'25: 0.43× (vs Q4'23)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.57) × ERP
WACC = 87% × Ke + 13% × Kd (5.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 11.91 Current price: 2.55
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
1 Rev. Ana.
1 EPS Ana. 		Dec 2027
1 Rev. Ana.
1 EPS Ana.
Revenue
997.79M
est: 1.27B (-21.4%)
990.04M
est: 1.15B (-14.3%)
1.37B
est: 1.31B (+4.3%)
1.41B
est: 1.49B (-5.6%)
1.36B
est: 1.36B (-0.3%)
1.53B
1.53B – 1.53B
+12.1% YoY
1.67B
1.67B – 1.67B
+9.5% YoY
EBITDA
304.65M
est: 359.27M (-15.2%)
267.87M
est: 326.86M (-18.1%)
434.82M
est: 361.06M (+20.4%)
335.37M
est: 409.70M (-18.1%)
331.03M
est: 375.18M (-11.8%)
420.44M
420.44M – 420.44M
+12.1% YoY
460.40M
460.40M – 460.40M
+9.5% YoY
EBIT
221.13M
est: 270.83M (-18.4%)
212.00M
est: 246.40M (-14.0%)
311.46M
est: 266.96M (+16.7%)
247.09M
est: 302.93M (-18.4%)
242.06M
est: 277.40M (-12.7%)
310.87M
310.87M – 310.87M
+12.1% YoY
340.41M
340.41M – 340.41M
+9.5% YoY
Net Income
161.75M
est: 195.15M (-17.1%)
187.75M
est: 216.52M (-13.3%)
228.91M
est: 201.98M (+13.3%)
195.08M
est: 243.77M (-20.0%)
183.45M
est: 167.15M (+9.8%)
180.66M
180.66M – 180.66M
+8.1% YoY
195.11M
195.11M – 195.11M
+8.0% YoY
SGA
224.43M
est: 264.82M (-15.3%)
223.32M
est: 240.93M (-7.3%)
327.45M
est: 312.27M (+4.9%)
362.06M
est: 354.34M (+2.2%)
329.60M
est: 324.48M (+1.6%)
363.62M
363.62M – 363.62M
+12.1% YoY
398.18M
398.18M – 398.18M
+9.5% YoY
EPS
0.26
est: 0.28 (-7.9%)
0.27
est: 0.31 (-13.8%)
0.33
est: 0.29 (+13.8%)
0.28
est: 0.35 (-20.0%)
0.26
est: 0.24 (+8.4%)
0.26
0.26 – 0.26
+8.1% YoY
0.28
0.28 – 0.28
+8.0% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-29 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-28 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-27 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-26 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-22 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-21 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-20 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-19 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-18 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-15 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-14 A+ 4/5 5/5 4/5 5/5 3/5 3/5 4/5
2026-05-13 A+ 4/5 5/5 3/5 5/5 3/5 3/5 5/5
2026-05-12 A+ 4/5 5/5 3/5 5/5 3/5 3/5 5/5
2026-05-11 A+ 4/5 5/5 3/5 5/5 3/5 3/5 5/5
2026-05-08 A 4/5 5/5 3/5 4/5 3/5 3/5 5/5
2026-05-07 A 4/5 5/5 3/5 4/5 3/5 3/5 5/5
2026-05-06 A 4/5 5/5 3/5 4/5 3/5 3/5 5/5
2026-05-05 A+ 4/5 5/5 3/5 4/5 3/5 4/5 5/5
2026-05-04 A+ 4/5 5/5 3/5 4/5 3/5 4/5 5/5
2026-04-30 A+ 4/5 5/5 3/5 5/5 2/5 4/5 5/5
2026-04-29 A+ 4/5 5/5 3/5 5/5 2/5 4/5 5/5
2026-04-28 A+ 4/5 5/5 3/5 5/5 2/5 4/5 5/5
2026-04-27 A 4/5 5/5 3/5 5/5 2/5 4/5 4/5
2026-04-24 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-23 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-22 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-21 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-20 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-17 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5
2026-04-16 A 4/5 5/5 3/5 5/5 2/5 3/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
898.55M
OE per share TTM
1.30
Owner's Yield
50.06%
Maintenance CapEx ratio
95.97%
Maint CapEx / Avg PPE
53.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 State Street SPDR S&P Emerging Markets Small Cap ETF EWX 0.01% 67.9K 0.65%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
93.5K
Shares Outstanding
693.39M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Bozhou Zhang Chairman & Chief Executive Officer 2M male
Guangdi Zhang Joint Company Secretary & Executive Director 2M male
Junfeng Zhang Executive Director 750.5K male
Xiaoli Zhang Executive Director 750.5K female
Hongyan Liu Chief Operating Officer — male
Wai Kin Lo Company Secretary — male
Yajun Yang Chief Medical Officer — female
Jin Fu Chief Financial Officer — female
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities